University of West Attica
Διαχείριση στοματικής υγείας ασθενών με συμπαγείς όγκους υπό χημειοθεραπεία: αξιολόγηση ποιότητας ζωής: χρήση εφαρμογών (e-health)
Abstract
dc:descriptionIntroduction: The oral cavity constitutes a primary target of antineoplastic therapy and a critical factor for its successful outcome. Severe and extensive oral complica-tions occurring during and after the completion of antineoplastic treatment have been widely recognized at an international level. Oral mucositis, fungal, herpetic, and bacte-rial infections, xerostomia, dysphagia, odynophagia, and medication-related osteone-crosis of the jaws, which may develop during and following cancer therapy, signifi-cantly impair both oral health and overall quality of life in oncological patients. The World Dental Federation (FDI) and the oncological community currently recognize oral care in cancer patients as an “urgent need” and a public health issue, promoting multidisciplinary programs involving dentists, oncologists, nurses, and other healthcare professionals. The participation of the dentist within the oncology care team through-out all phases of patient management is essential, contributing to improved therapeutic outcomes and preservation of patients’ quality of life. Quantitative and qualitative al-terations of the oral microbiota, along with the development of local infections, under-score the significant role of the oral cavity in the emergence of systemic complications during antineoplastic therapy, highlighting the need for vigilance and continuous oral monitoring. These complications not only reduce patients’ quality of life but may also delay or compromise the effectiveness of oncological treatment. According to interna-tional clinical guidelines, such as those issued by MASCC/ISOO for oral health man-agement and the European Oral Care in Cancer Group (EOCC), preventive dental in-tervention constitutes an essential component of comprehensive oncological care. In Greece, although clinical recommendations exist from scientific societies such as the Hellenic Society of Head and Neck Oncology (HeSHNO), the implementation of sys-tematic oral care protocols within hospital settings remains limited. The integration of a specialized dentist into the oncology team could address this gap by providing indi-vidualized and evidence-based oral healthcare. Furthermore, post-treatment follow-up of oncological patients remains critical. Emerging evidence suggests that e-health ap-plications enable continuous remote monitoring of patients with chronic diseases, par-ticularly cancer patients, leading to reduced anxiety, earlier detection of oral complica-tions related to antineoplastic therapy, and improved therapeutic outcomes. Therefore, efforts aimed at risk reduction and early detection are both critical and necessary. Oral health is thus an integral component of holistic oncological care, while long-term fol-low-up ensures timely management of conditions that may affect patients’ quality of life or safety. Aim: The objectives of the present study were to conduct a multi-level investigation of the contribution of an integrated dental intervention combining face-to-face clinical assessment with telemedicine/e-health-based monitoring to oral health and quality of life in patients with solid tumors during and after completion of antineoplastic therapy. The study sought to evaluate the effectiveness of this intervention compared with standard clinical practice in oncology units, both in terms of prevention and manage-ment of oral complications and in relation to improvements in daily functioning and psychological well-being. Additionally, the study aimed to assess longitudinally the clinical impact of antineoplastic therapies on the oral mucosa, the degree of oral tox-icity, and the overall burden of oral health impairment. Furthermore, changes in pa-tients’ daily habits and lifestyle during the course of treatment were explored, along with the systematic documentation of epidemiological data related to disease burden and patient response. The extent and manner of telemedicine use for oral health man-agement were also examined, aiming to evaluate acceptance, accessibility, and func-tionality as supportive tools enhancing continuity of care. Finally, the association be-tween quality of life, psychological well-being, and the implementation of the inte-grated dental intervention with synchronous and asynchronous telemonitoring was documented, along with the identification of demographic and behavioral factors that may contribute to the development of targeted health policies for improving care and quality of life in oncological patients. Methodology: This study was designed as a randomized, prospective, comparative in-terventional study employing validated measurement scales and multiple data analysis methods. The study was conducted at the 2nd and 3rd Oncology Clinics and the outpa-tient departments of the Oncology Hospital of Kifisia, where clinical and radiographic dental examinations and follow-ups were performed between March 2022 and Novem-ber 2023. Three clinical and radiographic assessments of oral health and quality of life were carried out during this period. The study sample consisted of 105 patients diag-nosed with solid tumors of the breast, lung, and colorectal region, who were receiving chemotherapy or combined therapy for the first time according to a predefined treat-ment protocol. Inclusion criteria included adulthood, histologically confirmed diagno-sis of a solid tumor, no prior chemotherapy, adequate general health status to partici-pate (ECOG 0–2), sufficient proficiency in the Greek language to provide informed consent, and basic familiarity with smartphone and/or computer use, or permanent co-habitation with an individual possessing such skills. Patients in the control group re-ceived standard oncology unit care and were advised to visit a dentist prior to treat-ment initiation, while independently managing their dental care. In the intervention group, a structured, individualized oral health management program was implemented by the principal investigator, including face-to-face clinical and radiographic examina-tions at the beginning, midpoint, and end of antineoplastic therapy, as well as synchro-nous and asynchronous monitoring through a digital platform between clinical visits. Existing oral health problems were addressed at treatment initiation, and patients were instructed and trained to use the electronic platform for prompt reporting of oral symp-toms. Results: Telemedicine significantly improved psychological status, oral health, and oral hygiene behavior among oncological patients compared with the instruction-only group. Comparative analyses demonstrated a clear superiority of the telemedicine group across multiple domains. Specifically: (a) Psychological status: Anxiety scores (HADS-Anxiety) decreased significantly at mid-treatment and at the end of therapy in the telemedicine group, whereas the control group showed improvement only relative to baseline. Depression scores (HADS-Depression) showed a significant reduction exclusively in the telemedicine group at the end of treatment. (b) Oral health: At mid-treatment and at treatment completion, the telemedicine group exhibited lower rates of oral lesions, gingival bleeding, gingivitis, dental caries, and periodontitis compared with the control group. (c) Oral hygiene behavior: Tooth-brushing frequency was significantly higher in the telemedicine group throughout the treatment period. (d) Oral function and quality of life indices: The telemedicine group demonstrated sig-nificant improvements in pain, xerostomia, and eating difficulties (EORTC OH-15), as well as in functional status, global health, and symptom management (EORTC QLQ-C30), both at mid-treatment and at treatment completion. All statistical analyses were conducted using SPSS version 21.00. All tests were two-sided, and a p-value <0.05 was considered statistically significant. Overall, the findings indicate that telemedicine constitutes an effective supportive tool for oncological pa-tients, improving psychological well-being, oral health, and overall quality of life dur-ing and after completion of cancer therapy. Conclusions: Oral health represents a critical component of overall health, sharing common etiological mechanisms with systemic diseases and interacting bidirectionally with them. Quantitative and qualitative changes in oral microbiota and the develop-ment of local infections highlight the significant role of the oral cavity in preventing systemic complications during antineoplastic therapy. Early identification and man-agement of oral complications are essential for maintaining treatment schedules, re-ducing morbidity, and preserving patients’ quality of life. The inclusion of the dentist within the oncology care team for prevention, diagnosis, and treatment of oral conditions contributes significantly to the success of cancer ther-apy. Telemedicine and e-health applications constitute effective tools for monitoring, early detection of complications, and patient guidance in oral health matters, without requiring immediate hospital visits. Their use improves oral health, supports psycho-logical well-being, and enhances overall quality of life throughout and following can-cer treatment. The present study proposes a structured protocol for supportive oral care in oncological patients, the broader and multicenter application of which may form the basis for the development of comprehensive clinical practice guidelines and protocols, supporting the institutional integration of dental care within the overall oncological treatment plan and contributing to improved quality of life for oncological patients.
Degree
thesis:*- Grantor dc:publisher
- University of West Attica
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Petropoulou, Pinelopi
- Πετροπούλου, Πηνελόπη
Subjects
dc:subject × 28- Στοματική υγεία
- Ποιότητα ζωής
- Ογκολογικοί ασθενείς
- Χημειοθεραπεία
- Εφαρμογές e-health
- Καρκίνος
- Συμπαγείς όγκοι
- Στοματολογία
- Ογκολογία
- Oral health
- Quality of life
- Oncology patients
- Chemotherapy
- E-health applications
- Cancer
- Solid tumours
- Oral medicine
- Oncology
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Οδοντιατρική, Γναθοπροσωπική χειρουργική και Στοματολογία
- Επιστήμες Υγείας
- Νοσηλευτική
- Clinical Medicine
- Medical and Health Sciences
- Dentistry, Oral Surgery and Medicine
- Health Sciences
- Nursing
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62025